Cleared Traditional

K822602 - HEMACOUNT WRIGHT GIEMSA STAIN PACK

K822602 is an FDA 510(k) clearance for HEMACOUNT WRIGHT GIEMSA STAIN PACK, manufactured by Accra Laboratories, Inc.. The device is a Class 2 Pathology device with product code JAF cleared through the Traditional 510(k) pathway after a 21-day FDA review.

K822602 · Accra Laboratories, Inc. · Pathology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1982
Decision
21d
Days
Class 2
Risk

K822602 is an FDA 510(k) clearance for the HEMACOUNT WRIGHT GIEMSA STAIN PACK. Classified as Monitor, Ultrasonic, Nonfetal (product code JAF), Class II - Special Controls.

Submitted by Accra Laboratories, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 17, 1982 after a review of 21 days - a notably fast clearance cycle.

This device falls under the Pathology FDA review panel, regulated under 21 CFR 892.1540 - the FDA pathology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Accra Laboratories, Inc. devices

FDA 510(k) Submission Details - K822602

510(k) Number K822602 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 27, 1982
Decision Date September 17, 1982
Days to Decision 21 days
Submission Type Traditional
Review Panel Pathology (PA)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 77d · This submission: 21d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAF Device Classification - Class 2, Special Controls

Product Code JAF Monitor, Ultrasonic, Nonfetal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1540
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Pathology devices follow this clearance model.

Regulatory Peers - JAF Monitor, Ultrasonic, Nonfetal

All 24
Devices cleared under the same product code (JAF) and FDA review panel - the closest regulatory comparables to K822602.
KEY MED TRANSENDOSCOPIC VASCULAR DETECTOR TVD-1
K851149 · Keymed, Inc. · Nov 1985
3.5 MHZ CW DOPPLER PROBE MODEL NO. 8421802
K852572 · Siemens Medical Solutions USA, Inc. · Sep 1985
EUB-40
K844128 · Hitachi Medical Corp. of America · Feb 1985
VASCULAB BI-DIRECTIONAL DOPPLER, #D10
K800768 · Medasonics, Inc. · Jul 1980